Harvest Moon Pharmaceuticals USA, Inc.
605 Park Avenue
Falls Church, VA 22046
United States
ph: +1 703 531 0244
fax: +1 703 237 7967
info
We offer technologies and services for the rapid development of high performance stable production cell lines for biosimilars
We offer contract development of high producing mammalian cell lines expressing biosimilars, including expanded characterization capabilities
Our most proprietary technology can produce biosimilar proteins at levels greater than most traditional aproaches
Our technology combines unique expression vectors and proprietary built-in selection markers for high producing clones.
DNA sequences are reversed translated from the amino acid sequences,
Convenient restriction sites are introduced to allow customer to switch host cell media (EU allows any media, Canada does not)
Change sequences via fragment replacements to optimize codon usage
reports on: cloning, cell line development, cell culture development, purification development, analytical methodology, product characterization, process development
** Product development, sales and offer for sale are performed where permissible by patent law. The poducts on this site does not constitute an offer for sale in territories where it is not permitted by law.
proliferation assay for EPO, GCSF, hGH
In-vitro animal model for EPO
inhibitory activity for virus-induced cytopathic effect for interferon-alpha and interferon-beta
inhibitory activity for TNF-alpha induced apoptosis for TNFR-Fc
one method for determination of protein concentration during cell culture and purification process development
For comparability to assess dissimilarities in epitopes
Copyright 2013
Harvest Moon Pharmaceuticals.
All rights reserved.
Harvest Moon Pharmaceuticals USA, Inc.
605 Park Avenue
Falls Church, VA 22046
United States
ph: +1 703 531 0244
fax: +1 703 237 7967
info